| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Elżbieta Skrzydlewska | Q24451883 |
| Mariola Sulkowska | Q115945813 | ||
| Stanisław Sulkowski | Q115945836 | ||
| Mariusz Koda | Q57340344 | ||
| P2860 | cites work | Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members | Q22001456 |
| A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 | ||
| Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins | Q24312902 | ||
| "In vitro" digestion of intact bovine lens capsules by four human lysosomal cysteine-proteinases | Q68920162 | ||
| Hypochlorous acid (HOCl) activation of neutrophil collagenase requires cathepsin G | Q69357918 | ||
| Evidence that alpha-tocopherol functions cyclically to quench free radicals in hepatic microsomes. Requirement for glutathione and a heat-labile factor | Q69455122 | ||
| Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells | Q69518256 | ||
| Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency | Q69736915 | ||
| Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients | Q70487759 | ||
| Procathepsin D cannot autoactivate to cathepsin D at acid pH | Q70612684 | ||
| Exposure of cells to nonlethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization | Q70954078 | ||
| Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) rece | Q71019291 | ||
| Biochemical characterization of human collagenase-3 | Q24318765 | ||
| Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 | Q24322566 | ||
| Lysosomal cysteine proteases: facts and opportunities | Q24535678 | ||
| Tissue inhibitors of metalloproteinases: evolution, structure and function | Q28138083 | ||
| Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer | Q28138684 | ||
| Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells | Q28142712 | ||
| Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis | Q28209992 | ||
| Analysis of a truncated form of cathepsin H in human prostate tumor cells | Q28215805 | ||
| Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 | ||
| Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis | Q28268059 | ||
| Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells | Q28276790 | ||
| Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion | Q28284948 | ||
| Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D | Q28287089 | ||
| Cathepsin D inactivates cysteine proteinase inhibitors, cystatins | Q28294092 | ||
| Molecular cloning and sequence analysis of human preprocathepsin C | Q28295805 | ||
| The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family | Q28303305 | ||
| Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage | Q28378843 | ||
| Matrix metalloproteinase degradation of extracellular matrix: biological consequences | Q28611041 | ||
| NADPH oxidase: an update | Q28611494 | ||
| Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease | Q28618841 | ||
| Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties | Q28618856 | ||
| AP-1 function and regulation | Q29618422 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
| Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells | Q30321132 | ||
| Cysteine proteinases in cancer progression and their clinical relevance for prognosis | Q30430037 | ||
| Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer. | Q30661648 | ||
| The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. | Q33185804 | ||
| Molecular regulation, membrane association and secretion of tumor cathepsin B. | Q33586435 | ||
| Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix | Q77452924 | ||
| Cathepsin D activity in colorectal cancer | Q77459540 | ||
| The collagenolytic activity of cathepsin K is unique among mammalian proteinases | Q77581104 | ||
| Alpha1-antitrypsin deficiency allele carriers among lung cancer patients | Q77817785 | ||
| Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site | Q77926967 | ||
| Regulation of cathepsin B activity by cysteine and related thiols | Q77931595 | ||
| Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma | Q78029650 | ||
| High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer | Q78167050 | ||
| Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices | Q78801720 | ||
| Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression | Q80493769 | ||
| Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma | Q95721627 | ||
| Mechanisms for pro matrix metalloproteinase activation. | Q33586441 | ||
| Proteolytic control of growth factor availability | Q33586464 | ||
| Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. | Q33586489 | ||
| An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases | Q33586496 | ||
| Membrane-type matrix metalloproteinases | Q33586502 | ||
| Clinical studies with matrix metalloproteinase inhibitors | Q33586513 | ||
| Matrix metalloproteinases and their inhibitors in tumour growth and invasion | Q33603385 | ||
| Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Matrix metalloproteinases in tumour invasion and metastasis | Q33765792 | ||
| Unraveling the role of proteases in cancer | Q33838143 | ||
| Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview | Q33838156 | ||
| Role of reactive oxygen species in apoptosis: implications for cancer therapy. | Q33845327 | ||
| Lysosomal cysteine proteases: more than scavengers | Q33857460 | ||
| Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells | Q33866629 | ||
| Role of cysteine endopeptidases in cancerogenesis | Q33941771 | ||
| Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis | Q33989842 | ||
| Phagocytes and oxidative stress | Q33998363 | ||
| NADPH oxidase: a universal oxygen sensor? | Q34054215 | ||
| Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization | Q34132949 | ||
| Protein damage and degradation by oxygen radicals. I. general aspects | Q34163421 | ||
| The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. | Q34177082 | ||
| Matrix metalloproteinases and bladder cancer | Q34207068 | ||
| Structure and variation of human alpha 1-antitrypsin | Q34277158 | ||
| Inflammation, carcinogenesis and cancer | Q34372773 | ||
| Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. | Q34476924 | ||
| Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins | Q34515383 | ||
| Cysteine proteinases in tumor cell growth and apoptosis | Q34531907 | ||
| A radical approach to cancer. | Q34598467 | ||
| Inflammation and the development of pancreatic cancer | Q34646491 | ||
| Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
| Myeloperoxidase-mediated protein oxidation: its possible biological functions | Q34734560 | ||
| Superoxide dismutase: an emerging target for cancer therapeutics | Q35050415 | ||
| Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion | Q35186457 | ||
| A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis | Q35341297 | ||
| The role of lipid peroxidation and antioxidants in oxidative modification of LDL. | Q35379559 | ||
| Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase | Q35588784 | ||
| Free radical-mediated oxidation of free amino acids and amino acid residues in proteins | Q35602220 | ||
| The matrix metalloproteinases and their inhibitors | Q35673430 | ||
| Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. | Q35683359 | ||
| Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck | Q35763849 | ||
| Tumor-associated urokinase-type plasminogen activator: biological and clinical significance | Q35777083 | ||
| Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. | Q35779496 | ||
| Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. | Q35782300 | ||
| Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants | Q36220582 | ||
| Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis | Q36235778 | ||
| Expression of MMP-2,TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance | Q36308445 | ||
| TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma | Q36421730 | ||
| Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. | Q36431062 | ||
| A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. | Q36524591 | ||
| Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking | Q36641357 | ||
| Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha | Q36803725 | ||
| Autocatalytic activation of human cathepsin K. | Q36861164 | ||
| Hyperexpression of mitogen-activated protein kinase in human breast cancer | Q37365431 | ||
| Isolation of cDNA sequences coding for a part of human tissue plasminogen activator | Q37601324 | ||
| Role of oxidatively modified LDL in atherosclerosis | Q37978587 | ||
| Structure, function, and control of neutrophil proteinases | Q38189037 | ||
| Tissue destruction by neutrophils | Q38264463 | ||
| Interactions between oxygen free radicals and proteins. Implications for rheumatoid arthritis. An overview | Q38760764 | ||
| Plasminogen activators, tissue degradation, and cancer | Q39476382 | ||
| Plasminogen activator inhibitors | Q39592746 | ||
| Lipid peroxidation and mechanisms of toxicity | Q39673575 | ||
| Elastase in tissue injury | Q39819526 | ||
| Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation | Q40096626 | ||
| Human plasma proteinase inhibitors | Q40107740 | ||
| Superoxide Radical: An Endogenous Toxicant | Q40135917 | ||
| Tumor invasion and the extracellular matrix | Q40139457 | ||
| Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents | Q40274090 | ||
| Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils | Q40377931 | ||
| Lipid peroxidation and antioxidants as biomarkers of tissue damage | Q40381864 | ||
| The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. | Q40475378 | ||
| Oxidation of methionyl residues in proteins: tools, targets, and reversal | Q40615542 | ||
| Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors | Q40652154 | ||
| The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center | Q40709282 | ||
| H(2)O(2)-induced AP-1 activation and its effect on p21(WAF1/CIP1)-mediated G2/M arrest in a p53-deficient human lung cancer cell | Q40726746 | ||
| Modulation of redox signal transduction pathways in the treatment of cancer | Q40787729 | ||
| Evidence for the photoprotective effects of vitamin E. | Q40866769 | ||
| Biology and biochemistry of proteinases in tumor invasion. | Q40868702 | ||
| Molecular aspects of tumor cell invasion and metastasis | Q40877783 | ||
| Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells | Q40895491 | ||
| Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase | Q40906347 | ||
| Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis | Q40918506 | ||
| EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP. | Q40943385 | ||
| Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells | Q40944816 | ||
| Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line | Q41035774 | ||
| 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells | Q41044903 | ||
| Photo-Oxidative Disruption of Lysosomal Membranes Causes Apoptosis of Cultured Human Fibroblasts | Q41138991 | ||
| Cathepsin B expression in human tumors | Q41154912 | ||
| Cystatins in health and disease | Q41161690 | ||
| Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin | Q41174195 | ||
| Biological and clinical significance of cathepsin D in breast cancer metastasis | Q41248368 | ||
| Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. | Q41444177 | ||
| Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors | Q41482008 | ||
| Activation mechanisms of matrix metalloproteinases. | Q41482018 | ||
| Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. | Q41489908 | ||
| Computational sequence analysis of the tissue inhibitor of metalloproteinase family | Q41502913 | ||
| The urokinase-type plasminogen activator system in cancer metastasis: A review | Q41522331 | ||
| Integrins and anoikis | Q41612562 | ||
| Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. | Q41628042 | ||
| Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation | Q41643679 | ||
| Physiological mechanisms for metalloproteinase activation | Q41647723 | ||
| Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer | Q41674938 | ||
| Characterization of a cathepsin-H-like enzyme from a human melanoma cell line | Q41675121 | ||
| MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. | Q41681960 | ||
| Candidate genes for the hypoxic tumor phenotype. | Q41723494 | ||
| Cathepsin B and human tumor progression | Q41730404 | ||
| Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues | Q41849893 | ||
| Biosynthesis of lysosomal cathepsins B and H in cultured rat hepatocytes | Q41912213 | ||
| Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines | Q42050993 | ||
| Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis | Q42064268 | ||
| Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis | Q42064476 | ||
| Protein damage and degradation by oxygen radicals. II. Modification of amino acids | Q42206650 | ||
| Are cancer cells acidic? | Q42372356 | ||
| Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. | Q42441199 | ||
| Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells | Q42460524 | ||
| Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane | Q42471774 | ||
| Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization | Q42482705 | ||
| Immunohistochemical localization of cathepsin D in colorectal tumors | Q42485500 | ||
| Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer | Q42498864 | ||
| Identification and characterization of a novel human cathepsin L splice variant | Q42812237 | ||
| Multiple processing of procathepsin L to cathepsin L in vivo | Q42824669 | ||
| Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. | Q43507844 | ||
| The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. | Q43654457 | ||
| Antioxidant status and lipid peroxidation in colorectal cancer. | Q43762098 | ||
| Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis | Q43765113 | ||
| A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. | Q43785805 | ||
| Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides | Q43825780 | ||
| Activity of cathepsin H in blood and biopsies of patients with precancerous conditions and mouth cancer | Q43850330 | ||
| Cathepsin D in breast cancer: a tissue marker associated with metastasis | Q43902552 | ||
| Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species | Q43945265 | ||
| Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients | Q44062343 | ||
| Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines | Q44164221 | ||
| Cathepsin K mRNA and protein expression in prostate cancer progression | Q44303172 | ||
| Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease | Q71091006 | ||
| Formation of alpha-tocopherol complexes with fatty acids. A hypothetical mechanism of stabilization of biomembranes by vitamin E | Q71385811 | ||
| Integrin signaling | Q71443713 | ||
| Glutathione-dependent protection against lipid peroxidation in sheep liver microsomes | Q71585808 | ||
| Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells | Q71679363 | ||
| Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins | Q71935429 | ||
| Immunohistochemical localization of human alpha 2Macroglobulin in connective tissue | Q72626598 | ||
| Stromal expression of c-Ets1 transcription factor correlates with tumor invasion | Q72710487 | ||
| Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid | Q72871320 | ||
| Free radical and enzymatic mechanisms for the generation of protein bound reducing moieties | Q72947369 | ||
| Growth factors in the extracellular matrix | Q73075408 | ||
| VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix | Q73119438 | ||
| Prediction of the extent of prostate cancer by the combined use of systematic biopsy and serum level of cathepsin D | Q73173195 | ||
| Cathepsin D cytosol content in colorectal cancer | Q73199449 | ||
| Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells | Q73209050 | ||
| Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers | Q73341681 | ||
| Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates | Q73371430 | ||
| Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma | Q73374461 | ||
| Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma | Q73404082 | ||
| Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide | Q73422907 | ||
| Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion | Q73447520 | ||
| Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme | Q73451641 | ||
| Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis | Q73471075 | ||
| Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators | Q73483295 | ||
| Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines | Q73502998 | ||
| Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas | Q73812406 | ||
| Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma | Q73828612 | ||
| Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions | Q73838292 | ||
| Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells | Q73855117 | ||
| Analysis of cathepsin D in human breast cancer: usefulness of the processed 31 kDa active form of the enzyme as a prognostic indicator in node-negative and node-positive patients | Q73875608 | ||
| Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands | Q73876250 | ||
| Immunohistochemical evaluation of cathepsin D expression in colorectal cancer | Q73931435 | ||
| Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression | Q73949261 | ||
| Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study | Q73977482 | ||
| Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma | Q74130349 | ||
| Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma | Q74215987 | ||
| Cathepsin D expression in early cutaneous malignant melanoma | Q74261737 | ||
| Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells | Q74312758 | ||
| Comparative localization of cathepsin B protein and activity in colorectal cancer | Q74320260 | ||
| Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis | Q74625032 | ||
| Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9 | Q74657550 | ||
| Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer | Q77321922 | ||
| Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer | Q77407088 | ||
| [The activity of cathepsin B in colorectal adenocarcinomas] | Q77430901 | ||
| Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate | Q77449371 | ||
| Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma | Q77449401 | ||
| Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment | Q44392056 | ||
| Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer | Q44527477 | ||
| Neutrophil elastase and cathepsin G: structure, function, and biological control. | Q44568294 | ||
| Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. | Q44607068 | ||
| Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. | Q45887759 | ||
| Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. | Q45992111 | ||
| Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. | Q46214973 | ||
| Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation | Q46314983 | ||
| The secretion of high molecular weight cathepsin B from cultured human liver cancers | Q47174373 | ||
| Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis | Q47981823 | ||
| The direct cause of photodamage-induced lysosomal destabilization. | Q50528374 | ||
| Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. | Q50857430 | ||
| Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy. | Q52971270 | ||
| Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma | Q53461208 | ||
| Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. | Q53730579 | ||
| Expression and the role of cathepsin H in human glioma progression and invasion. | Q55479498 | ||
| Cathepsin B expression and localization in glioma progression and invasion. | Q55481523 | ||
| Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases | Q57696102 | ||
| Proteolytic inactivation of human α1 antitrypsin by human stromelysin | Q57925646 | ||
| Inhibition of neutrophil superoxide production by human plasma α1 -antitrypsin | Q57925662 | ||
| Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients | Q59709159 | ||
| Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications | Q60245921 | ||
| Cathepsins B, H and L in human breast carcinoma | Q67848008 | ||
| A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells | Q67919923 | ||
| Antileukoprotease, its role in the human lung | Q67988520 | ||
| Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma | Q68201720 | ||
| Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils | Q68448621 | ||
| Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases | Q68482295 | ||
| Glutathione disulfide enhances the reduced glutathione inhibition of lipid peroxidation in rat liver microsomes | Q68706266 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | carcinogenesis | Q1637543 |
| proteolysis | Q33123 | ||
| P304 | page(s) | 1251-1266 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Proteolytic-antiproteolytic balance and its regulation in carcinogenesis | |
| P478 | volume | 11 |
| Q36948156 | A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique |
| Q39893638 | A method in enzymology for measuring hydrolytic activities in live cell environments |
| Q27303204 | A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival |
| Q38256644 | A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair |
| Q40009124 | Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling |
| Q33955648 | Activity of cathepsin D and α1-antitrypsin in blood of men with malignant melanoma |
| Q41709011 | Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo |
| Q37725921 | Are proteinases the reason for keratoconus? |
| Q36548227 | BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells |
| Q33479201 | Bioactive substances produced by marine isolates of Pseudomonas |
| Q39428092 | Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, in vitro |
| Q30499994 | Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration |
| Q40097138 | Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis |
| Q81139923 | Changes in electric charge and phospholipids composition in human colorectal cancer cells |
| Q39499972 | Collagen IV-derived peptide binds hydrophobic cavity of Legionella pneumophila Mip and interferes with bacterial epithelial transmigration |
| Q31041476 | Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data |
| Q43294277 | Cysteine protease-mediated cytoskeleton interactions with LFA-1 promote T-cell morphological changes |
| Q39441083 | Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. |
| Q43049939 | Differential expression of degradome components in cutaneous squamous cell carcinomas |
| Q38891004 | Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma |
| Q35643955 | Effect of Fasciola hepatica proteins on the functioning of rat hepatocytes. |
| Q28566238 | Effect of plant neutrophil elastase inhibitor on leucocyte migration, adhesion and cytokine release in inflammatory conditions |
| Q37906480 | Exploiting the tumor microenvironment for theranostic imaging |
| Q62050223 | Gene expression and the biological phenotype of papillary thyroid carcinomas |
| Q39691175 | Gene expression profiles in 3D tumor analogs indicate compressive strain differentially enhances metastatic potential |
| Q37601854 | High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer |
| Q36259662 | Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism. |
| Q36801110 | IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity |
| Q87673231 | Inhibition of cathepsin B activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q48822832 | Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface |
| Q57696089 | Interaction between Human Cathepsins K, L, and S and Elastins |
| Q36414502 | Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion |
| Q54399678 | Localization of cathepsins D and B at the maternal-fetal interface and the invasiveness of the trophoblast during the postimplantation period in the mouse. |
| Q43846955 | Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling |
| Q33889595 | MALDI tissue imaging: from biomarker discovery to clinical applications. |
| Q43211711 | Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase |
| Q51352083 | Mitigation of DMBA-induced mammary carcinoma in experimental rats by antiangiogenic property of Kalpaamruthaa. |
| Q35064453 | Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade |
| Q40199605 | Nicotine treatment induces expression of matrix metalloproteinases in human osteoblastic Saos-2 cells |
| Q39897383 | Opposite effects of protein kinase C beta1 (PKCbeta1) and PKCepsilon in the metastatic potential of a breast cancer murine model |
| Q28571500 | Oxidative Modifications of Rat Liver Cell Components During Fasciola hepatica Infection |
| Q36143607 | PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor. |
| Q37777976 | Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target. |
| Q40102424 | Protein kinase C delta inhibits the production of proteolytic enzymes in murine mammary cells. |
| Q37343319 | Proteolytic networks in cancer |
| Q34851058 | Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer |
| Q35879132 | RNA sequencing identifies crucial genes in papillary thyroid carcinoma (PTC) progression |
| Q51578366 | Reactive oxygen species and melanoma: an explanation for gender differences in survival? |
| Q54207274 | Sensitive molecular detection of small nodal metastasis in uterine cervical cancer using HPV16-E6/CK19/MUC1 cancer biomarkers. |
| Q38855481 | Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9. |
| Q33664639 | Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. |
| Q98192661 | Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory Activity |
| Q46084536 | Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate |
| Q47171613 | The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells |
| Q57201221 | The expression of prolactin and its cathepsin D-mediated cleavage in the bovine corpus luteum vary with the estrous cycle |
| Q36661278 | Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease |
| Q38132176 | Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer |
| Q40281247 | Urokinase plasminogen activator receptor (uPAR) expression is reduced by tyrosine kinase inhibitors |
| Q37309834 | Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. |
| Q36075298 | mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma. |
Search more.